New FDA-Approved Treatment for RKD

The FDA has approved Ultomiris for adults with IgA Nephropathy (IgAN). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Rachel Slattery

Director, Events Strategy

Rachel Slattery serves as the Director of Event Strategy for NephCure. Before joining the team in May 2019, she started her career in the event planning industry at the Chamber of Commerce for Greater Philadelphia and has experience coordinating small to large scale events of all types from start to finish. Rachel is passionate about turning events into unforgettable experiences and helping others along the way. In her spare time, she loves to travel, hike and spend time with her Maltipoo dog, Peanut!

King of Prussia, PA

Related News

NEWS

The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy 

NEWS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.